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Background: The medical literature includes two risk scores predicting the occurrence of abdominal wound
dehiscence. These risk indices were validated by the authors on the populations studied. However, whether these
scoring systems can accurately predict, abdominal wound dehiscence in other populations remains unclear.
Methods: A retrospective analysis was performed using the medical records of patients treated at a tertiary-care
teaching hospital between 2008 and 2011. Patients that underwent laparotomy procedures complicated by the
development of postoperative abdominal wound dehiscence were included into the study. For each of the cases,
three controls were selected.
Results: Among the 1,879 patients undergoing intra-abdominal, 56 patients developed wound dehiscence and 168
patients included in the control group. Calculation of risk scores for all patients, revealed significantly higher scores in
the abdominal wound dehiscence group (p < 0.001). The median score was 24 (range: 3–46) and 4.95 (range: 2.2-7.8)
vs.10 (range:-3-45) and 3.1 (range:0.4-6.9), for the Veterans Affairs Medical Center (VAMC) and Rotterdam abdominal
wound dehiscence risk score in the dehiscence and control groups, respectively. The area under the curve, on the ROC
plot, was 0.84 and 0.76; this confirmed a good and moderate predictive value for the risk scores. The fit of the model
was good in both cases, as shown by the Hosmer and Lemeshow test.
Conclusions: Both the VAMC and Rotterdam scores can be used for the prediction of abdominal wound dehiscence.
However, the VAMC prognostic score had better calibration and discriminative power when applied to the population
in this study and taking into consideration our method of control selection.
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Abdominal wound dehiscence is one of the most serious
postoperative complications; the incidence in the adult
population is reported as 0.3-3.5%, and among the elderly
it is as high as 10%. In about 20-45% of cases, evisceration
becomes a significant risk factor, which is associated with
death during the perioperative period [1,2]. Several publi-
cations have indentified risk factors associated with this
complication; however, many of the reports have conflict-
ing results. Two papers, by van Ramshorst GH et al. in
2010 and Webster C et al. in 2003, reported on a scoring* Correspondence: jkenig@cm-uj.krakow.pl
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unless otherwise stated.system that was developed based on multivariable stepwise
logistic regression models of preoperative, intraoperative
and postoperative variables that were entered sequentially
as independent predictors of wound dehiscence. Both risk
indices were validated by the authors of these studies based
on the populations studied; they aided clinical management
[3,4]. However, whether these scoring systems can accur-
ately predict abdominal wound dehiscence in other popula-
tions remains unclear.Methods
Selection of patients
A retrospective analysis was performed using the medical
records of patients treated at a tertiary-care teaching hos-
pital from January 2008 to December 2011. The studytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline characteristics of patient from the
dehiscence and control group
Factor Study group Control group P value
Number (male/female): 56 (37/19) 168 (95/73) 0.210
Age [years] 66.6 ± 13 66.8 ± 12.8 0.872
Type of the procedure [n]: 0.276
- Elective 11 (20%) 44 (26%)
- Emergency 45 (80%) 124 (74%)
Type of operation [n]:
- Stomach/duodenum 5 (9%) 14 (8%) 0.898
- Gall bladder 5 (9%) 13 (8%) 0.794
- Small intestine 9 (16%) 36 (21%) 0.475
- Large intestine 27 (49%) 83 (49%) 0.928
- Others 10 (16%) 22 (13%) 0.450
Opening of the bowel [n] 42 (76%) 122 (73%) 0.163
Malignancy [n] 24 (44%) 71 (42%) 0.858
Co-morbidities [n]:
- Hypertension 28 (51%) 92 (55%) 0.619
- Heart disease 23 (42%) 61 (36%) 0.464
- Diabetes 8 (14%) 28 (17%) 0.711
- COPD 9 (16%) 16 (9%) 0.163
- Other 42 (76%) 116 (69%) 0.326
BMI:<20.5/20.5-30/>30 kg/m2 [n] 12/31/13 24/119/24 0.123
Past operations [n] 25 (45.5%) 91 (54%) 0.261
Smoking [n] 15 (27.3%) 41 (24%) 0.670
Chronic steroids use [n] 7 (12.7%) 6 (4%) 0.011
Wound infection 34 (61%) 23 (14%) <0.001
Anastomotic insufficiency 5 (9%) 5 (3%) 0.768
Circulatory insufficiency [n] 21 (37%) 43 (26%) 0.042
Median laparotomy [n] 47 (84%) 143 (85%) 0.952
Retention sutures [n] 13 (23%) 27 (16%) 0.173
Time of op. [n]:
7–15.00 24 (43%) 81 (48%) 0.681
15.01-23.59 26 (46%) 73 (43%) 0.729
00.00-6.59 6 (11%) 14 (8.3%) 0.890
ICU admission [n] 25 (45%) 39 (23%) 0.001
Length of hospital. [days] 38.3 ± 27.1 15.8 ± 12.9 <0.001
Biochemical factors:
- WBC [103/μl] 12.5 ± 6.0 11.6 ± 5.9 0.260
- HCT [%] 35.9 ± 7.2 37.7 ± 6.4 0.096
- HGB [g/dl] 12.2 ± 4.6 12.4 ± 2.2 0.669
- CRP [mg/l] 127.13 ± 108.2 111.49 ± 100.27 0.476
- Albumin [g/l] 30.2 ± 12.9 32.69 ± 9.6 0.260
- Protein [g/l] 52.44 ± 13.9 56.85 ± 13.8 0.167
- Creatinine [μmol/l] 104.4 ± 62.5 91.98 ± 63.7 0.308
Time to dehiscence [days] 9.8 ± 6.5 -
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procedures complicated by postoperative abdominal wound
dehiscence, defined as “separation of the layers of the surgi-
cal wound, partial or complete, with disruption of the
fascia”. The study used case–control methodology with
reversed-flow design. For each case, three controls were se-
lected that had laparotomy procedures, were matched for a
similar period of time (time interval from 1 day to 1 month),
age (±2-3 years), gender, diagnosis of underlying disease,
and type of surgery performed. Patients that had open ab-
domen procedures were excluded.
Data collection
Preoperative patient characteristics including risk factors,
intra- and peri- operative processes of care, and postoper-
ative adverse occurrences were recorded based on both
electronic and paper medical records. Other data such as
laboratory values and culture results were pulled into the
dataset from other computerized sources. Particular em-
phasis was placed on the analysis of the factors described
in both publications mentioned above.
Definition of factors used in this study
1. Wound infection occurrence was recorded in the
database when at least one of the following was
observed within 30 days after the operation:
purulent drainage (culture documentation not
required), organisms are isolated from fluid/tissue, at
least one sign of inflammation (pain or tenderness,
induration, erythema, local warmth of the wound),
the wound was deliberately opened by the surgeon
or the surgeon declared the wound infected.
2. Anemia: a blood hemoglobin level less than 12 g/dl
3. Jaundice: the total level of bilirubin in blood serum
3 mg/dl or higher.
4. Postoperative coughing was defined as coughing
documented by nurses in the patient charts before
the diagnosis of abdominal wound dehiscence, or
before discharge in patients without abdominal
wound dehiscence.
5. Ascites - accumulation of fluid in the peritoneal
cavity on clinical examination and/or visible on
ultrasound.
Prognostic scores
The two published abdominal wound dehiscence risk indi-
ces were used in this study. The first one was based on data
from the Veterans Affairs National Surgical Quality Im-
provement Program (NSQIP) used at 132 Veterans Affairs
Medical Centers between October 1996 and September
2000, hereinafter referred to as the VAMC risk score. The
second index was based on medical registers developed
from January 1985 to December 2005 at an academic
Table 3 Rotterdam score variables and characteristics of
the validation population
Variables of the
Rotterdam score
Abdominal wound
dehiscence [n = 56]
No abdominal
wound dehiscence
[n = 168]
P value
Age category
40–49 12% 11% 0.744
50–69 48% 45% 0.815
>70 39% 44% 0.691
Male gender 66% 56% 0.502
Chronic
pulmonary disease
16% 9% 0.163
Ascites 4% 0% 0.110
Jaundice 7% 4% 0.399
Anemia 61% 16% <0.001
Emergency
surgery
80% 74% 0.715
Type of surgery
Gallbladder/
bile duct
9% 8% 0.794
Esophagus 0% 0% 1.000
Stomach and
duodenum
9% 8% 0.794
Small bowel 16% 21% 0.520
Large bowel 49% 49% 0.964
Vascular 0% 0% 1.000
Coughing 21% 3% <0.001
Wound
infection
61% 14% <0.001
Table 4 Area under ROC curve for each score (area+/−SE)
and the odds ratio (OR) as a risk coefficient for the
abdominal wound dehiscence score and dehiscence
AUC SE P value OR 95% CI for OR
VAMC score 0.84 0.03 <0.001 1.1 1.1-1.2
Rotterdam score 0.76 0.04 <0.001 2.2 1.7-2.9
AUC – area under the curve (ROC), OR – odds radio, SE – standard error of
area, type I error probability of area.
Table 2 VAMC score variables and characteristics of the
validation population
Variables of
the VAMC score
Abdominal wound
dehiscence
[n = 56]
No abdominal
wound dehiscence
[n = 168]
P value
CVA/stroke
no deficit
9% 5% 0.280
History COPD 16% 9% 0.163
Current
pneumonia
12% 4% 0.081
Emergency
procedure
80% 74% 0.715
Operative
time >2.5 h
37% 40% 0.834
PGY4 23% 25% 0.833
Clean wound
classification
23% 27% 0.683
Superficial
wound infection
21% 10% 0.053
Deep wound
infection
39% 4% <0.001
Failure to wean 21% 16% 0.448
One or more
complications
70% 42% 0.032
Return to OR 0% 0% 1.000
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to as the Rotterdam risk score. Detailed information on
these indices can be found in the relevant publications
[3,4]. For both indices a higher value predicts a higher risk.
Missing data
Patients with missing data associated with risk factors of
interest were excluded from the study. For the rest of the
patients included in the final analysis, data were missing
for 3% of the patients in the dehiscence group and 2% in
the control group.
Statistical analysis
Qualitative and quantitative data were used to describe
the study results. Quantitative parameters are expressed as
the mean value ± standard deviation or median (range) as
appropriate. The remaining cases were summarized as
counts and percentages. The data were analyzed using the
Statistica 10.0 software suite (StatSoft). The Shapiro-Wilk
W and the Kolmogorov-Smirnov tests, with the Killiefors
correction, were used to verify the normality of the distri-
bution of the results. Based on these analyses, the data
were analyzed using parametric or non-parametric tests.
Validation of the scores was performed using standard
tests to measure calibration and discrimination. The dis-
criminatory ability of the scores in predicting abdominal
wound dehiscence was measured using the area under
the receiver operating characteristic curve (AUC).Sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) were calculated
using standard formulas for each score. A comparison
between the AUCs was performed using the χ2 test. The
calibration of the predicted to the observed development
of abdominal wound dehiscence was measured using the
Hosmer-Lemeshow goodness-of-fit statistic for 10 covar-
iate groups, whenever possible. Statistical significance
was defined as a two-sided p ≤ 0.05.
The retrospective access to the database has been ap-
proved by the review board of the 3rd Department of
General Surgery Jagiellonian University Medical College.
Table 5 The correct and misclassification error probabilities (%) of both abdominal wound dehiscence risk score at
optimal cut off values and at values used in primary publications
Specificity (%) Sensitivity (%) False + (%) False – (%) PPV (%) NPV (%) Accuracy (%) Cut off value
VAMC score 94% 48% 5% 50% 75% 85% 83% 25 points
70% 82% 29% 18% 48% 92% 73% 14 points*
Rotterdam score 98% 20% 2% 80% 73% 78% 78% 5.8 points
71% 73% 29% 27% 45% 89% 71% 3.8 points*
*Cut off values used in primary publications.
Kenig et al. BMC Surgery 2014, 14:65 Page 4 of 6
http://www.biomedcentral.com/1471-2482/14/65Results
Patient characteristics
Among the 1,879 patients undergoing intra-abdominal
procedures during the study period 56 patients were in-
cluded in the validation group; the patients developed
wound dehiscence during the postoperative period and
represented 2.9% of all operations performed. The
group consisted of 37 men and 19 women; there was a
statistically significant difference with regard to gender,
men accounted for more of the cases (p = 0.034). The
mean age was 66.8 ± 12.6 years. Abdominal wound de-
hiscence occurred on average at the 9.8 ± 6.5 postopera-
tive day (median: 8 days). The mortality of patients in
this group was 25%. In addition, more patients were op-
erated on as a emergency procedures 45 (80.4%) vs. 11
patients in the elective group, this difference was statis-
tically significant (p <0.001). There were 168 patients in
the control group based on the above mentioned cri-
teria. The baseline characteristics of the patients are re-
ported in Table 1.
The patients that developed abdominal wound dehis-
cence had a higher rate of wound infection, circulatory
insufficiency, increased length of hospitalization and
were more likely admitted to the ICU; these differences
were statistically significant. The other factors studied
did not show statistically significant differences.Table 6 Comparing discriminatory ability and calibration
among various scores for the wound dehiscence
Risk score Are under
ROC curve
Hosmer-Lemeshow
(9 groups)
P value
VAMC score 0.84 6.75 0.461
Rotterdam score 0.76 12.4 0.083Comparison of predicted dehiscence risk
Calculation of risk scores for all patients revealed signifi-
cantly higher scores in both abdominal wound dehis-
cence groups (p < 0.001). The median scores were 24
(range: 3–46) and 4.95 (range: 2.2-7.8) vs. 10 (range: −3-
45) and 3.3 (range: 0.4-6.9), for the VAMC and Rotterdam
abdominal wound dehiscence risk score in the dehiscence
and control groups, respectively (p < 0.001). Tables 2 and
3 are showing the VAMC and Rotterdam scores variables
and characteristics of the validation population.
The relationship between all scores was statistically
significant. The area under the curve, in the ROC plot,
was 0.84 and 0.76 respectively, showing a good and
moderate predictive value of the risk scores (Table 4).
However, the VAMC score more successfully predicted
patients that would develop dehiscence.The odds ratio as risk coefficient was examined using
a binary logistic regression model. When the VAMC and
Rotterdam scores increased by one unit the predicted
odds changed by a multiplicative factor of 1.1 and 2.2,
respectively. This indicates that for an increase of 1
point, on both risk scores, the risk of abdominal wound
dehiscence increases 1.1 and 2.2 times (Table 4).
The efficacy of both scores for predicting abdominal
wound dehiscence during the postoperative period can
be defined as sensitivity and its efficacy in predicting a
complication free course (in terms of dehiscence) de-
fined as specificity. The values of the VAMC and Rotter-
dam scores are shown in Table 5. These results are
presented at optimal cut off values and at the values
used in primary publications. In the calculations, two
types of errors of abdominal wound dehiscence scores
were investigated. These can be referred to as the false
positive and negative results (Table 5).Comparison of discrimination
Table 6 shows that the overall area under the receiver
operating characteristic curve for wound dehiscence was
0.84 and 0.76, for VAMC and Rotterdam scores, respect-
ively. The AUC under the VAMC curve was significantly
higher than the Rotterdam curve (p < 0.001), indicating a
better discriminatory ability.Calibration of prediction scores
The fit of the model was good in both cases, as shown
by the Hosmer and Lemeshow test (p = 0.461 and p =
0.083, respectively, as it is shown in Table 6). However,
in the case of the VAMC score the calibration was sig-
nificantly better.
Kenig et al. BMC Surgery 2014, 14:65 Page 5 of 6
http://www.biomedcentral.com/1471-2482/14/65Discussion
Prior studies have identified several risk factors associated
with the development of abdominal wound dehiscence,
such as: age (>65 years old), gender (male), smoking, obes-
ity, chronic steroid therapy, anemia, jaundice, uremia, dia-
betes, low albumin level, chronic obstructive pulmonary
disease (COPD), cancer, wound infection, and emergency
surgery [5-11]. The results of this study indicate that
wound dehiscence is a complex process that is influenced
by factors both of a general and local nature, as well as
pre-, intra-and postoperative timing. Only the common
occurrence of a number of factors lead to the development
of this complication. Most of the risk factors do not de-
pend directly on the surgeon, but rather on patient factors
such as: gender, age, type of disease to be treated, mode of
surgery, and chronic steroid use. No significant differences
were observed between the study and control groups with
regard to diabetes, COPD, anemia, uremia, jaundice, and
the albumin levels. However, consistent with the findings
of other publications, the most important risk factor for
the development of abdominal wound dehiscence was a
surgical site infection.
Scoring systems are designed to estimate the probabil-
ity of occurrence of an undesired event. Such systems can
be used to aid clinical management, resource allocation and
quality assessment. There are only two scoring systems in
the medical literature that are used for determining the risk
for developing an abdominal wound dehiscence; the popu-
lations studied validated both. However, external validation
is essential before a scoring system is applied to a group of
patients different from the one originally used for model
development.
This is the first study to compare the validity of the re-
ported indices in our population. Both the VAMC and
Rotterdam scores can be used to predict abdominal wound
dehiscence. The relationships between all scores were sta-
tistically significant and the area under the curve of the
ROC plot showed a good (0.84) and moderate (0.76) pre-
dictive value. However, in this study the VAMC score
showed a significantly better discriminatory ability.
Moreover, the VAMC score had better calibration com-
pared to the Rotterdam score. This is due the fact that
the Rotterdam score consists of many variables that our
control group was matched for (age, gender, emergency
surgery, type of surgery). Among the variables, only the
VAMC score included the risk factor of emergency pro-
cedures. In addition, the population studied here may
be more similar to the population in the VAMC study
with more co-morbidities than the general population.
Furthermore, the Rotterdam score was designed to
avoid excessive inclusion of emergency operations in
the control group. The population assessed in this
study, was more like the VAMC population with regard
to the number of emergency operations; which weresignificantly higher compared to elective procedures. In
the study by Gomez Diaz et al., authors also concluded that
the Rotterdam score has same limitations in the preopera-
tive assessment and additional refinements are needed to
improve accuracy. This is mainly due to the fact that its
comprises a list of postoperative factors, including, the key
factor in the assessment, surgical wound infection [12].
The limitations of this study include the following. The
design was a retrospective analysis. However, the data were
validated as thoroughly as possible. In addition, the data is
from a single centre, which limits the generalization of the
findings. The use of matching cases and controls could
have affected the sensitivity and specificity of tests. How-
ever, the study was designed to reduce the number of con-
founding variables. Both scores could be used to distinguish
patients with a high risk for abdominal wound dehiscence
that had similar disease and type of surgery.
Conclusion
In conclusion, both the VAMC and Rotterdam score indi-
ces can be used to predict the development of abdominal
wound dehiscence. The VAMC prognostic score had bet-
ter calibration and discriminative power when applied to
the population evaluated in this study and taking into con-
sideration our method of control selection. Moreover,
these scores can be used to distinguish patients at high
risk for developing abdominal wound dehiscence that have
similar diseases and undergo similar surgical procedures.
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